GE HealthCare Technologies Inc. $GEHC Stock Purchased by Mather Group LLC.

Mather Group LLC. lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 86.2% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 85,945 shares of the company’s stock after purchasing an additional 39,796 shares during the period. Mather Group LLC.’s holdings in GE HealthCare Technologies were worth $5,618,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. Mount Vernon Associates Inc. MD grew its position in GE HealthCare Technologies by 0.8% in the 1st quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after acquiring an additional 144 shares during the last quarter. Essex Financial Services Inc. increased its stake in GE HealthCare Technologies by 1.8% in the first quarter. Essex Financial Services Inc. now owns 9,024 shares of the company’s stock worth $642,000 after purchasing an additional 156 shares during the period. Brown Lisle Cummings Inc. increased its stake in GE HealthCare Technologies by 29.3% in the first quarter. Brown Lisle Cummings Inc. now owns 706 shares of the company’s stock worth $50,000 after purchasing an additional 160 shares during the period. Beacon Financial Advisory LLC increased its stake in GE HealthCare Technologies by 5.8% in the first quarter. Beacon Financial Advisory LLC now owns 2,965 shares of the company’s stock worth $211,000 after purchasing an additional 162 shares during the period. Finally, Physician Wealth Advisors Inc. boosted its stake in shares of GE HealthCare Technologies by 60.4% during the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock valued at $31,000 after purchasing an additional 163 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Up 2.7%

NASDAQ:GEHC opened at $70.35 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a 50-day moving average of $68.58 and a 200 day moving average of $66.77. The firm has a market cap of $31.78 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 1.81 and a beta of 0.73. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.06 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is currently 3.67%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of research analyst reports. Oppenheimer restated an “outperform” rating on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Evercore reiterated an “outperform” rating and set a $84.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $75.00 to $71.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Zacks Research raised shares of GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of GE HealthCare Technologies in a research note on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average price target of $78.35.

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology and healthcare services company that develops, manufactures and supports products used by hospitals, clinicians and researchers. Its offerings are designed to assist with disease detection, diagnosis, treatment, patient monitoring and clinical workflow management.

The company’s portfolio includes computed tomography, magnetic resonance imaging, X-ray and molecular imaging systems; ultrasound equipment; patient monitoring and anesthesia delivery technologies; and pharmaceutical diagnostics, including contrast agents used in medical imaging.